Fungal metabolites modulating NF-κB activity: An approach to cancer therapy and chemoprevention (review)

Oncology Reports

Volumn 19, Issue 2, 2008, Pages 299-308

  Petrova, Roumyana D ^a,b,c   Reznick, Abraham Z ^c   Wasser, Solomon P ^b   Denchev, Cvetomir M ^d   Nevo, Eviatar ^b   Mahajna, Jamal ^a  

^a MIGAL GALILEE TECHNOLOGY CENTER   (Israel)

^b UNIVERSITY OF HAIFA   (Israel)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^d INSTITUTE OF BIODIVERSITY AND ECOSYSTEM RESEARCH   (Bulgaria)

Author keywords

Chemoprevention; Fungal metabolites; Nuclear transcription factor B activity

Indexed keywords

ACETIC ACID ETHYL ESTER; ALCOHOL; ANTINEOPLASTIC AGENT; BETA GLUCAN; CAFFEIC ACID PHENETHYL ESTER; CORDYCEPIN; DITERPENOID; ERGOSTEROL; ETHER; FATTY ACID; GANODERMA LUCIDUM EXTRACT; HERICIUM ERINACEUM EXTRACT; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LECTIN; MANNITOL; METHANOL; NATURAL PRODUCT; PLEUROTUS OSTREATUS EXTRACT; PLEUROTUS PULMONARIUS EXTRACT; POLYSACCHARIDE; PROSTAGLANDIN SYNTHASE; SCHIZOPHYLLAN; SCHIZOPHYLLUM COMMUNE EXTRACT; SESQUITERPENE DERIVATIVE; STEROL DERIVATIVE; TERPENE DERIVATIVE; TRAMETES GIBBOSA EXTRACT; UNCLASSIFIED DRUG; UNINDEXED DRUG;

AGARICUS BISPORUS; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; CANCER ADJUVANT THERAPY; CANCER CELL; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CARCINOGENESIS; CELL DIFFERENTIATION; CELL MEMBRANE TRANSPORT; CELL SURVIVAL; CHEMOPROPHYLAXIS; DRUG RESEARCH; DRUG STRUCTURE; ENZYME ACTIVATION; FUNGAL METABOLISM; GANODERMA LUCIDUM; HERICIUM ERINACEUM; HUMAN; IMMUNOSTIMULATION; INFLAMMATION; LENTINUS EDODES; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; MOLECULAR MECHANICS; MOLECULAR THERAPY; MONOTHERAPY; MUSHROOM; NONHUMAN; PLEUROTUS; PLEUROTUS OSTREATUS; PLEUROTUS PULMONARIUS; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; REVIEW; SCHIZOPHYLLUM COMMUNE; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; TRAMETES; TRAMETES GIBBOSA;

EID: 38749106120     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.19.2.299     Document Type: Review

References (62)

1. Pahl H: Activators and target genes of Rel/NF-κB transcription factors. Oncogene 18: 6853-6866, 1999.
2. Zandi E and Karin M: Bridging the gap: composition, regulation and physiological function of the IκB kinase complex. Mol Cell Biol 19: 4547-4551, 1999.
3. Karin M and Ben-Neriah Y: Phosphorylation meets ubiquitination: The control of NF-[κ]B activity. Ann Rev Immunol 18: 621-663, 2000.
4. Karin M, Cao Y, Greten FR and Li ZW: NF-κB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2: 301-310, 2002.
5. Magné N, Toillon RA, Bottero V, Didelot C, Houtte PV and Gérard JP: NF-κB modulation and ionizing radiation: mechanisms mad future directions for cancer treatment. Cancer Lett 231: 158-168, 2006.
6. Hanahan D and Weinberg RA: The hallmarks of cancer. Cell 100: 57-70, 2000.
7. Karin M: Nuclear factor kappaB in cancer development and progression. Nature 441: 431-436, 2006.
8. Petrova RD, Wasser SP, Mahajna JA, et al: Potential role of medicinal mushrooms in breast cancer treatment: current knowledge and future perspectives. Int J Med Mushr 7: 141-156, 2005.
9. Mattila P, Könkö K, Eurola M, et al: Contents of vitamins, mineral elements and some phenolic compounds in cultivated mushrooms. J Agric Food Chem 49: 2343-2348, 2001.
10. Nakamura T, Akiyama Y, Matsugo S, et al: Purification of caffeic acid as an anti-oxidant from submerged culture mycelia of Phellinus linteus (Berk. et Curt.) Teng (Aphyllophoromycetidae). Int J Med Mushr 5: 163-167, 2003.
11. Park YM, Kim IT, Park HJ, et al: Anti-inflammatory and antinociceptive effects of the methanol extract of Fomes fomentarius. Biol Pharm Bull 27: 1588-1593, 2004.
12. Erkel G, Anke T and Sterner O: Inhibition of NF-κB activation by panepoxydone. Biochem Biophys Res Commun 226: 214-221, 1996.
13. Wasser SP and Weis AL: Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: A modern perspective. Crit Rev Immunol 19: 65-96, 1999.
14. Ossowski L and Lopez MR: Proteolytic enzymes in cancer invasion. Introduction. Enzyme Prot 49: 5-6, 1996.
15. Mizuno T, Saito H, Nishitoba T and Kawagishi H: Anti-tumor-active substances from mushrooms. Food Rev Int 11: 23-61, 1995.
16. Yoshida I, Kiho T, Usui S, et al: Polysaccharides in fungi. XXXVII. Immunomodulating activities of carboxymethylated derivatives of linear (1-3)-alpha-d-glucans extracted from the fruiting bodies of Agrocybe cylindracea and Amanita muscaria. Biol Pharm Bull 19: 114-121, 1996.
17. Zhao CG, Sun H, Tong X and Qi YP: An anti-tumor lectin from edible mushroom Agrocybe aegerita. Biochem J 374: 321-327, 2003.
18. Zhang Y, Mills GL and Nair MG: Cyclooxygenase inhibitory and anti-oxidant compounds from the fruiting body of ma edible mushroom, Agrocybe aegerita. Phytomedicine 10: 386-390, 2003.
19. Petrova RD, Mahajna J, Reznick AZ, et al: Fungal substances as modulators of NF-κB activation pathway. Mol Biol Rep 34: 145-154, 2007.
20. Lorenzen K and Anke T: Basidiomycetes as a source for new bioactive natural products. Curr Organic Chem 2: 329-364, 1998.
21. Warner RL, Winter HC, Speyer CL, et al: Marasmius oreades lectin induces renal thrombotic microangiopathic lesions. Exp Mol Pathol 77: 77-84, 2004.
22. Hu H, Ahn NS, Yang X, et al: Ganoderma lucidum extracts induce cell cycle arrest and apoptosis in MCF-7 human breast cancer cell. Int J Cancer 102: 250-253, 2002.
23. Lu Q-Y, Sartippour MR, Brooks MN, et al: Ganoderma lucidum spore extract inhibits endothelial and breast cancer cells in vitro. Oncol Rep 12: 659-662, 2004.
24. Sliva D, Labarrere C, Slivova V, et al: Ganoderma lucidum suppresses motility of highly invasive breast and prostate cancer cells. Biochem Biophys Res Commun 298: 603-612, 2002.
25. Sliva D, Sedlak M, Slivova V, et al: Biological activity of Ganoderma lucidum for the inhibition of highly invasive breast and prostate cancer cells. J Altern Compl Med 9: 491-497, 2003.
26. Zaidman BZ, Wasser SP, Nevo E and Mahajna J: Coprinus comatus and Ganoderma lucidum interfere with androgen receptor function in LNCaP prostate cancer cells. Mol Biol Rep 2007 Mar 13. DOI: 10.1007/ s11033-007-9059-5.
27. Wasser SP and Weis AL: Medicinal properties of substances occurring in higher Basidiomycetes. Int J Med Mushr 1: 31-62, 1999.
28. Yoshioka Y, Ikekawa T, Noda M and Fukuoka F: Studies on anti-tumor activity of some fractions from Basidiomycetes. I. An anti-tumor acidic polysaccharide fraction of P. ostreatus (Fr.) Quél. Chem Pharm Bull 20: 1175-1180, 1972.
29. Buswell JA and Chang ST: Edible Mushrooms: Attributes and Applications. In: Genetics and Breeding of Edible Mushrooms. Chang ST, Buswell JA and Miles PG (eds.) Gordon and Breach, Amsterdam, pp297-324, 1993.
30. Lindequist U, Niedermeyer THJ and Julich WD: The pharmacological potential of mushrooms, eCAM 2: 285-299, 2005.
31. Jong SC and Donovick R: Anti-tumor and anti-viral substances from fungi. Adv Appl Microbiol 34: 183-261, 1989.
32. Grube BJ, Eng ET, Kao Y-C, et al: White button mushroom phytochemicals inhibit aromatase activity and breast cancer cell proliferation. J Nutr 131: 3288-3293, 2001.
33. Yassin M, Mahajna JA and Wasser SP: Submerged cultured mycelium extracts of higher Basidiomycetes mushrooms selectively inhibit proliferation and induce differentiation of K562 human chronic myelogenous leukemia cells. Int J Med Mushr 5: 261-276, 2003.
34. Allbutt AD, Ayer WA, Brodie HJ, et al: Cyathin, a new antibiotic complex produced by Cyathus helenae. Can J Microbiol 17: 1401-1407, 1970.
35. Anke T, Oberwinkler F, Steglich W and Höfle G: The striatins - new antibiotics from the basidiomycete Cyathus striatus (Huds. ex Pers.) Willd. J Antibiot 30: 221-225, 1976.
36. Ooi VEC and Liu F: Immunomodulation and anti-cancer activity of polysaccharide-protein complexes. Curr Med Chem 7: 715-729, 2000.
37. Zhuang C, Mizuno T, Shimada A, et al: Anti-tumor protein-containing polysaccharides from a Chinese mushroom Fengweigu or Houbitake, Pleurotus sajor-caju (Fr.) Sing. Biosci Biotech Biochem 57: 901-906, 1993.
38. Jose N, Aiith TA and Jananrdhan KK: Anti-oxidant, anti-inflammatory and anti-tumor activities of culinary-medicinal mushroom Pleurotus pulmonarius (Fr.) Quel. (Agarico-mycetidae). Int J Med Mushr 4: 329-335, 2002.
39. Chang ST and Miles PG: Edible Mushrooms and their Cultivation. Boca Raton, CRC Press, FL, p345, 1989.
40. Ito H, Sugiura M and Miyazaki T: Anti-tumor polysaccharide fraction from the culture filtrate of Fomes fomentarius. Chem Pharm Bull 24: 2575, 1976.
41. Capasso L: 5300 years ago the Ice Man used natural laxatives and antibiotics. Lancet 352: 1864, 1998.
42. Hashimoto T, Nonaka Y, Minato K, et al: Suppressive effect of polysaccharides from the edible and medicinal mushrooms, Lentinus edodes and Agaricus blazei, on the expression of cytochrome P450s in mice. Biosci Biotechnol Biochem 66: 1610-1614, 2002.
43. Son C, Shin J, Cho J, et al: Induction of murine interleukin-1 beta expression by water-soluble components from Hericium erinaceum. Acta Pharmacol Sin 27: 1058-1064, 2006.
44. Son CG, Shin JW, Cho JH, Cho CK, Yun CH, Chung W and Han SH: Macrophage activation and nitric oxide production by water soluble components of Hericium rerinaceum. Int Immunopharmacol 6: 1363-1369, 2006.
45. Umezawa K: Inhibition of tumor growth by NF-κB inhibitors. Cancer Sci 97: 990-995, 2006.
46. Rether J, Erkel G, Anke T and Stemer O: Inhibition of inducible TNF-α expression by oxaspirodion, a novel spiro-compound from the ascomycete Chaetomium subspirale. Biol Chem 385: 829-834, 2004.
47. Ohno N, Harada T, Masuzawa S, et al: anti-tumor activity and hematopoietic response of a β-glucan extracted from and edible and medicinal mushroom Sparassis crispa Wulf.: Fr. (Aphyllo-phoromycetidae). Int J Med Mushr 4: 13-26, 2002.
48. Ohno N, Miura NN, Nakajima M and Yadomae T: Anti-tumor 1,3-β-glucan from cultured fruit body of Sparassis crispa. Biol Pharm Bull 23: 866-872, 2000.
49. Ohno N, Nameda S, Harada T, et al: Immunomodulating activity of a β-glucan preparation, SCG, extracted from a culinary-medicinal mushroom, Sparassis crispa Wulf.: Fr. (Aphyllophoromycetidae), and application to cancer patients. Int J Med Mushr 5: 359-368, 2003.
50. Kuznecovs S and Kuznecova G: Phallus impudicus in treatment of Lewis lung carcinoma. XVII International Congress of Allergology and Clinical Immunology - ICACI XVII, Sydney, p421, 2000.
51. Kuznecovs S, Jegina K, Kuznecovs I and Kuznecova G: Phallus impudicus in thromboembolic disease prevention in cancer. Abstracts of the 16th MASCC International Symposium Miami Beach, FL, p379, 2004.
52. Mahajna JA, Yassin M and Wasser SP: Mushroom extracts having anti-cancer activity. U.S. Patent Ser. No. 7,258,862 issued Aug 21,2007.
53. Yoshida J, Takamura S, Yamaguchi N, et al: Anti-tumor acitivity of an extract of Cordyceps sinensis (Berk.) Sacc. against murine tumor cell lines. Jpn J Exp Med 59: 157-161, 1989.
54. Chen GZ, Chen GL, Sun T, et al: Effects of Cordyceps sinensis on murine T lymphocyte subsets. Chinese Med J 104: 4-8, 1991.
55. Chen YJ, Shiao MS, Lee SS and Wang SY: Effect of Cordyceps sinensis on the proliferation and differentiation of human leukemic U937 cells. Life Sci 60: 2349-2359, 1997.
56. Bok JW, Lermer L, Chilton J, et al: anti-tumor sterols from the mycelium of Cordyceps sinensis. Phytochemistry 51: 891-898, 1999.
57. Wang BJ, Won SJ, Yu ZR and Su CL: Free radical scavenging and apoptotic effects of Cordyceps sinensis fractionated by supercritical carbon dioxide. Food Chem Toxicol 43: 543-552, 2005.
58. Lull C, Wichers HJ and Savelkoul HFG: Anti-inflammatory and immunomodulating properties of fungal metabolites. Mediators Inflamm 2: 63-80, 2005.
59. Kim HG, Shrestha B, Lim SY, Yoon DH, Chang WC, Shin DJ, Han SK, Park SM, Park JH, Park H, Sung JM, Jang Y, Chung N, Hwang KC and Kim TW: Cordycepin inhibits lipopoly-saccharide-induced inflammation by the suppression of NF-κB through Akt and p38 inhibition in RAW 264.7 macrophage cells. Eur J Pharmacol 545: 192-199, 2006.
60. Park YM, Won JH, Kim YH, Choi JW, Park HJ and Lee KT: In vivo and in vitro anti-inflammatory and anti-nociceptive effects of the methanol extract of Inonotus obliquus. J Ethnopharmacol 101: 120-128, 2005.
61. Kim GY, Han MG, Song YS, Shin BC, Shin Y, Lee HJ, Moon DO, Lee CM, Kwak JY, Bae YS, Lee JD and Park YM: Proteoglycan isolated from Phellinus linteus induces toll-like receptors 2- and 4-mediated maturation of murine dendritic cells via activation of ERK, p38, and NF-κB. Biol Pharm Bull 27: 1656-1662, 2004.
62. Hsieh T, Wu P, Park S and Wu JM: Induction of cell cycle changes and modulation of apoptogenic/anti-apoptotic and extracellular signaling regulatory protein expression by water extracts of I'm-Yunity™ (PSP). BMC Compl Altern Med, 2006 Sep 11; 6:30. DOI: 10.1186/ 1472-6882-6-30.